-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BjVMFG4YEzwrw15VgIlrr1nTa1h/51KxBUnUsEcCGvr4ZfNKV1Xotb/P2NbdfxAd bIFwdoabvVaVPStynp5QUQ== 0001169232-06-002765.txt : 20060614 0001169232-06-002765.hdr.sgml : 20060614 20060614141145 ACCESSION NUMBER: 0001169232-06-002765 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060601 FILED AS OF DATE: 20060614 DATE AS OF CHANGE: 20060614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUN PHARMA GLOBAL INC CENTRAL INDEX KEY: 0001197088 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31773 FILM NUMBER: 06904433 BUSINESS ADDRESS: STREET 1: SPARC AKOTA ROAD CITY: VADODARA STATE: A1 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHANGHVI DILIP S CENTRAL INDEX KEY: 0001249644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31773 FILM NUMBER: 06904432 BUSINESS ADDRESS: STREET 1: 1150 ELIJAH MCCOY CITY: DETROIT STATE: MI ZIP: 48202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUN PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0001197089 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31773 FILM NUMBER: 06904434 BUSINESS ADDRESS: STREET 1: SPARC AKOTA ROAD CITY: VADODARA STATE: K7 ZIP: 390020 BUSINESS PHONE: 01191228212128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CARACO PHARMACEUTICAL LABORATORIES LTD CENTRAL INDEX KEY: 0000887708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382505723 STATE OF INCORPORATION: MI FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 1150 ELIJAH MCCOY DR CITY: DETROIT STATE: MI ZIP: 48202 BUSINESS PHONE: 3138718400 MAIL ADDRESS: STREET 1: 1150 ELIJAH MCCOY DRIVE CITY: DETROIT STATE: MI ZIP: 48202 4 1 d06-68383_ex.xml X0202 4 2006-06-01 0 0000887708 CARACO PHARMACEUTICAL LABORATORIES LTD CPD 0001197089 SUN PHARMACEUTICAL INDUSTRIES LTD SPARC, TANDALJA VADODARA, GUJARAT K7 390 020 INDIA 0 0 1 0 0001197088 SUN PHARMA GLOBAL INC AKARA BUILDING 24 DE CASTRO STREET,WILKHAMS CLAY 1 ROAD TOWN TARTOLA D8 VIRGIN ISLANDS, BRITISH 0 0 1 0 0001249644 SHANGHVI DILIP S C/O SUN PHARMACEUTICAL INDUSTRIES LD. MAHAL INDUSTRIES ESTATE, MAHAKALI CAVES ANDHARI (EAST), MUMBIA K7 400 093 INDIA 1 1 1 0 (Chairman of the Board) Series B. Prefefrred Stock 0 2006-06-01 4 J 0 544000 A 2009-06-01 Common Stock 544000 11424000 I See Footnote The Series B preferred shares are convertible into common stock after three years (or immediately upon a change in control) on a one-to-one basis. Sun Pharma Global, Inc. ("Sun Global") earns 544,000 shares of Series B Preferred Stock for each technology transfer to Caraco of a generic drug by Sun Global when such drug passes its bioequivalency studies. In the event of the dissolution of Caraco, such shares have a preference equal to the value attributed to them on the dates on which they were earned. The value attributed as of June 1, 2006 was $8.05. The shares of Series B Preferred Stock remain outstanding until such time as they are converted into Common Stock. These shares are owned directly by Sun Global, Inc., which is a wholly-owned subsidiary of Sun Pharmaceutical Industries Limited ("Sun"). Dilip S. Shanghvi is the controlling shareholder of Sun. See Exhibit Index /s/ Jayesh Shah as attorney-in-fact, for Dilip S. Shanghvi, Chairman and Managing Director of Sun 2006-06-07 /s/ Jayesh Shah as attorney-in-fact, for Dilip S. Shanghvi, Director of Sun Global 2006-06-07 /s/ Jayesh Shah as attorney-in-fact, for Dilip S. Shanghvi 2006-06-07 EX-99.1 2 d06-68383_ex991.htm

Exhbit 99.1

 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned constitutes and appoints Mr. Jayesh Shah signing singly, the undersigned’s true and lawful attorney in fact and agent, with full power of substitution, and re-substitution for the undersigned and in the undersigned’s name, place and stead, in any and all capacities, to:

 

 

(1)

execute for and on behalf of the undersigned, in the undersigned’s respective capacities as officers, directors or shareholders of Caraco Pharmaceutical Laboratories, Ltd. (the “Company”), Forms 3, 4, 5 and ID and all other forms that may be required to be filed by the undersigned from time to time under Section 16(a), and Schedule 13D and all amendments thereto under Section 13, of the Securities Exchange Act of 1934 and the rules promulgated there under;

 

(2)

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute such forms, schedules and/or any amendments to such schedules and forms and timely file such schedules, forms or any amendments with the United states Securities and Exchange Commission and any stock exchange or similar authority; and

 

(3)

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of the attorney in fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by the attorney in fact pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as the attorney in fact may approve in the attorney in fact’s discretion.

 

The undersigned hereby grants to the attorney in fact full power and authority to do and perform each and every act and thing requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do in person, with full power of substitution or revocation, hereby ratifying and confirming all that the said attorney in fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorney in fact, in serving in such capacity at the request of the undersigned, is not assuming nor is the Company assuming, any of the undersigned’s responsibilities to comply with Sections 13 or 16 of the Securities Exchange Act of 1934.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, 5 and ID or any other forms under Section 16(a) or Schedule 13D and any amendments thereto of the Securities Exchange Act of 1934, or it is revoked by the undersigned in a signed writing delivered to the attorney in fact or will remain in full force and effect upto 31st March 2009, whichever is earlier.

 

 


 

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 16th day of March, 2006.

 

By: /s/ Dilip S. Shanghvi          

Name: Dilip S. Shanghvi

 

Sun Pharmaceutical Industries Limited

 

By: /s/ Dilip S. Shanghvi          

Name: Dilip S. Shanghvi

Its: The Chairman & Managing Director

 

Sun Pharma Global, Inc.

 

By: /s/ Dilip S. Shanghvi          

Name: Dilip S. Shanghvi

Its: Director

 

 

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----